nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2E1—prostate cancer	0.161	0.614	CbGaD
Zopiclone—CYP3A4—prostate cancer	0.102	0.386	CbGaD
Zopiclone—CYP2C8—Nilutamide—prostate cancer	0.0363	0.0861	CbGbCtD
Zopiclone—CYP2C8—Abiraterone—prostate cancer	0.03	0.0713	CbGbCtD
Zopiclone—CYP2E1—Estrone—prostate cancer	0.0291	0.069	CbGbCtD
Zopiclone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.028	0.0665	CbGbCtD
Zopiclone—CYP2C9—Bicalutamide—prostate cancer	0.0253	0.06	CbGbCtD
Zopiclone—CYP2C9—Nilutamide—prostate cancer	0.0253	0.06	CbGbCtD
Zopiclone—CYP2C8—Cabazitaxel—prostate cancer	0.0222	0.0528	CbGbCtD
Zopiclone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0194	0.046	CbGbCtD
Zopiclone—CYP2E1—Mitoxantrone—prostate cancer	0.0173	0.0411	CbGbCtD
Zopiclone—CYP2C9—Estrone—prostate cancer	0.0151	0.036	CbGbCtD
Zopiclone—CYP3A4—Bicalutamide—prostate cancer	0.0147	0.0349	CbGbCtD
Zopiclone—PTGS1—Etoposide—prostate cancer	0.0141	0.0335	CbGbCtD
Zopiclone—CYP3A4—Estramustine—prostate cancer	0.0137	0.0325	CbGbCtD
Zopiclone—CYP2C8—Estradiol—prostate cancer	0.0125	0.0296	CbGbCtD
Zopiclone—CYP3A4—Abiraterone—prostate cancer	0.0122	0.0289	CbGbCtD
Zopiclone—CYP3A4—Flutamide—prostate cancer	0.0122	0.0289	CbGbCtD
Zopiclone—CYP2C9—Capecitabine—prostate cancer	0.0115	0.0273	CbGbCtD
Zopiclone—CYP2E1—Etoposide—prostate cancer	0.0109	0.0259	CbGbCtD
Zopiclone—CYP3A4—Cabazitaxel—prostate cancer	0.00901	0.0214	CbGbCtD
Zopiclone—CYP3A4—Estrone—prostate cancer	0.00881	0.0209	CbGbCtD
Zopiclone—CYP2C9—Estradiol—prostate cancer	0.0087	0.0207	CbGbCtD
Zopiclone—CYP2C8—Etoposide—prostate cancer	0.00815	0.0193	CbGbCtD
Zopiclone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00785	0.0186	CbGbCtD
Zopiclone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00576	0.0137	CbGbCtD
Zopiclone—CYP3A4—Mitoxantrone—prostate cancer	0.00524	0.0124	CbGbCtD
Zopiclone—CYP3A4—Estradiol—prostate cancer	0.00506	0.012	CbGbCtD
Zopiclone—CYP3A4—Prednisone—prostate cancer	0.00435	0.0103	CbGbCtD
Zopiclone—CYP3A4—Etoposide—prostate cancer	0.0033	0.00784	CbGbCtD
Zopiclone—CYP3A4—Docetaxel—prostate cancer	0.00302	0.00718	CbGbCtD
Zopiclone—CYP3A4—Doxorubicin—prostate cancer	0.00225	0.00535	CbGbCtD
Zopiclone—CYP2C9—urine—prostate cancer	0.00151	0.0865	CbGeAlD
Zopiclone—CYP2E1—urine—prostate cancer	0.00143	0.082	CbGeAlD
Zopiclone—CYP3A4—urine—prostate cancer	0.00115	0.066	CbGeAlD
Zopiclone—TSPO—prostate gland—prostate cancer	0.000891	0.051	CbGeAlD
Zopiclone—GABRB3—prostate gland—prostate cancer	0.000809	0.0463	CbGeAlD
Zopiclone—GABRG3—testis—prostate cancer	0.000795	0.0455	CbGeAlD
Zopiclone—TSPO—seminal vesicle—prostate cancer	0.000753	0.0431	CbGeAlD
Zopiclone—TSPO—epithelium—prostate cancer	0.000655	0.0374	CbGeAlD
Zopiclone—GABRA5—testis—prostate cancer	0.000611	0.035	CbGeAlD
Zopiclone—TSPO—renal system—prostate cancer	0.000607	0.0347	CbGeAlD
Zopiclone—TSPO—urethra—prostate cancer	0.000596	0.0341	CbGeAlD
Zopiclone—GABRA3—testis—prostate cancer	0.000569	0.0326	CbGeAlD
Zopiclone—Eszopiclone—CYP3A4—prostate cancer	0.000524	1	CrCbGaD
Zopiclone—CYP2E1—prostate gland—prostate cancer	0.000515	0.0294	CbGeAlD
Zopiclone—PTGS1—prostate gland—prostate cancer	0.000496	0.0284	CbGeAlD
Zopiclone—GABRB2—testis—prostate cancer	0.000464	0.0265	CbGeAlD
Zopiclone—TSPO—bone marrow—prostate cancer	0.000459	0.0263	CbGeAlD
Zopiclone—CYP2E1—seminal vesicle—prostate cancer	0.000435	0.0249	CbGeAlD
Zopiclone—PTGS1—seminal vesicle—prostate cancer	0.000419	0.024	CbGeAlD
Zopiclone—CYP2C8—renal system—prostate cancer	0.000417	0.0238	CbGeAlD
Zopiclone—TSPO—testis—prostate cancer	0.000392	0.0224	CbGeAlD
Zopiclone—PTGS1—epithelium—prostate cancer	0.000364	0.0208	CbGeAlD
Zopiclone—GABRB3—testis—prostate cancer	0.000356	0.0204	CbGeAlD
Zopiclone—CYP2E1—renal system—prostate cancer	0.000351	0.0201	CbGeAlD
Zopiclone—CYP2E1—urethra—prostate cancer	0.000344	0.0197	CbGeAlD
Zopiclone—PTGS1—renal system—prostate cancer	0.000338	0.0193	CbGeAlD
Zopiclone—GABRA2—lymph node—prostate cancer	0.000307	0.0176	CbGeAlD
Zopiclone—TSPO—lymph node—prostate cancer	0.000284	0.0163	CbGeAlD
Zopiclone—CYP3A4—renal system—prostate cancer	0.000282	0.0161	CbGeAlD
Zopiclone—CYP2C8—testis—prostate cancer	0.000269	0.0154	CbGeAlD
Zopiclone—CYP2E1—testis—prostate cancer	0.000227	0.013	CbGeAlD
Zopiclone—PTGS1—testis—prostate cancer	0.000218	0.0125	CbGeAlD
Zopiclone—PTGS1—lymph node—prostate cancer	0.000158	0.00905	CbGeAlD
Zopiclone—Feeling abnormal—Etoposide—prostate cancer	4.06e-05	0.000197	CcSEcCtD
Zopiclone—Diarrhoea—Mitoxantrone—prostate cancer	4.05e-05	0.000197	CcSEcCtD
Zopiclone—Dry mouth—Capecitabine—prostate cancer	4.05e-05	0.000196	CcSEcCtD
Zopiclone—Vomiting—Estradiol—prostate cancer	4.04e-05	0.000196	CcSEcCtD
Zopiclone—Gastrointestinal pain—Etoposide—prostate cancer	4.03e-05	0.000196	CcSEcCtD
Zopiclone—Ill-defined disorder—Prednisone—prostate cancer	4.02e-05	0.000195	CcSEcCtD
Zopiclone—Rash—Estradiol—prostate cancer	4.01e-05	0.000195	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—prostate cancer	4.01e-05	0.000195	CcSEcCtD
Zopiclone—Dermatitis—Estradiol—prostate cancer	4.01e-05	0.000194	CcSEcCtD
Zopiclone—Anaemia—Prednisone—prostate cancer	4e-05	0.000194	CcSEcCtD
Zopiclone—Confusional state—Capecitabine—prostate cancer	4e-05	0.000194	CcSEcCtD
Zopiclone—Tachycardia—Docetaxel—prostate cancer	4e-05	0.000194	CcSEcCtD
Zopiclone—Headache—Estradiol—prostate cancer	3.98e-05	0.000193	CcSEcCtD
Zopiclone—Agitation—Prednisone—prostate cancer	3.98e-05	0.000193	CcSEcCtD
Zopiclone—Angioedema—Prednisone—prostate cancer	3.95e-05	0.000192	CcSEcCtD
Zopiclone—Infection—Capecitabine—prostate cancer	3.94e-05	0.000191	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—prostate cancer	3.93e-05	0.000191	CcSEcCtD
Zopiclone—Urticaria—Etoposide—prostate cancer	3.92e-05	0.00019	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—prostate cancer	3.91e-05	0.00019	CcSEcCtD
Zopiclone—Anorexia—Docetaxel—prostate cancer	3.9e-05	0.00019	CcSEcCtD
Zopiclone—Malaise—Prednisone—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Body temperature increased—Etoposide—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Abdominal pain—Etoposide—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—prostate cancer	3.9e-05	0.000189	CcSEcCtD
Zopiclone—Vertigo—Prednisone—prostate cancer	3.89e-05	0.000189	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—prostate cancer	3.89e-05	0.000189	CcSEcCtD
Zopiclone—Tachycardia—Capecitabine—prostate cancer	3.87e-05	0.000188	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—prostate cancer	3.87e-05	0.000188	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—prostate cancer	3.86e-05	0.000187	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—prostate cancer	3.84e-05	0.000186	CcSEcCtD
Zopiclone—Hyperhidrosis—Capecitabine—prostate cancer	3.83e-05	0.000186	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—prostate cancer	3.83e-05	0.000186	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—prostate cancer	3.82e-05	0.000185	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—prostate cancer	3.78e-05	0.000183	CcSEcCtD
Zopiclone—Anorexia—Capecitabine—prostate cancer	3.78e-05	0.000183	CcSEcCtD
Zopiclone—Nausea—Estradiol—prostate cancer	3.78e-05	0.000183	CcSEcCtD
Zopiclone—Vomiting—Mitoxantrone—prostate cancer	3.77e-05	0.000183	CcSEcCtD
Zopiclone—Convulsion—Prednisone—prostate cancer	3.75e-05	0.000182	CcSEcCtD
Zopiclone—Hypertension—Prednisone—prostate cancer	3.74e-05	0.000181	CcSEcCtD
Zopiclone—Rash—Mitoxantrone—prostate cancer	3.74e-05	0.000181	CcSEcCtD
Zopiclone—Dermatitis—Mitoxantrone—prostate cancer	3.73e-05	0.000181	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.73e-05	0.000181	CcSEcCtD
Zopiclone—Headache—Mitoxantrone—prostate cancer	3.71e-05	0.00018	CcSEcCtD
Zopiclone—Insomnia—Docetaxel—prostate cancer	3.7e-05	0.00018	CcSEcCtD
Zopiclone—Myalgia—Prednisone—prostate cancer	3.68e-05	0.000179	CcSEcCtD
Zopiclone—Paraesthesia—Docetaxel—prostate cancer	3.68e-05	0.000179	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—prostate cancer	3.68e-05	0.000178	CcSEcCtD
Zopiclone—Anxiety—Prednisone—prostate cancer	3.67e-05	0.000178	CcSEcCtD
Zopiclone—Dyspnoea—Docetaxel—prostate cancer	3.65e-05	0.000177	CcSEcCtD
Zopiclone—Somnolence—Docetaxel—prostate cancer	3.64e-05	0.000177	CcSEcCtD
Zopiclone—Discomfort—Prednisone—prostate cancer	3.64e-05	0.000177	CcSEcCtD
Zopiclone—Hypersensitivity—Etoposide—prostate cancer	3.63e-05	0.000176	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—prostate cancer	3.63e-05	0.000176	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.61e-05	0.000175	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—prostate cancer	3.61e-05	0.000175	CcSEcCtD
Zopiclone—Dyspepsia—Docetaxel—prostate cancer	3.61e-05	0.000175	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—prostate cancer	3.6e-05	0.000175	CcSEcCtD
Zopiclone—Insomnia—Capecitabine—prostate cancer	3.59e-05	0.000174	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—prostate cancer	3.58e-05	0.000174	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—prostate cancer	3.57e-05	0.000173	CcSEcCtD
Zopiclone—Paraesthesia—Capecitabine—prostate cancer	3.56e-05	0.000173	CcSEcCtD
Zopiclone—Decreased appetite—Docetaxel—prostate cancer	3.56e-05	0.000173	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—prostate cancer	3.54e-05	0.000172	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Docetaxel—prostate cancer	3.54e-05	0.000172	CcSEcCtD
Zopiclone—Asthenia—Etoposide—prostate cancer	3.54e-05	0.000172	CcSEcCtD
Zopiclone—Dyspnoea—Capecitabine—prostate cancer	3.54e-05	0.000172	CcSEcCtD
Zopiclone—Anaphylactic shock—Prednisone—prostate cancer	3.53e-05	0.000171	CcSEcCtD
Zopiclone—Fatigue—Docetaxel—prostate cancer	3.53e-05	0.000171	CcSEcCtD
Zopiclone—Nausea—Mitoxantrone—prostate cancer	3.52e-05	0.000171	CcSEcCtD
Zopiclone—Infection—Prednisone—prostate cancer	3.51e-05	0.00017	CcSEcCtD
Zopiclone—Constipation—Docetaxel—prostate cancer	3.5e-05	0.00017	CcSEcCtD
Zopiclone—Pain—Docetaxel—prostate cancer	3.5e-05	0.00017	CcSEcCtD
Zopiclone—Dyspepsia—Capecitabine—prostate cancer	3.49e-05	0.000169	CcSEcCtD
Zopiclone—Chills—Epirubicin—prostate cancer	3.49e-05	0.000169	CcSEcCtD
Zopiclone—Pruritus—Etoposide—prostate cancer	3.49e-05	0.000169	CcSEcCtD
Zopiclone—Tachycardia—Prednisone—prostate cancer	3.45e-05	0.000167	CcSEcCtD
Zopiclone—Decreased appetite—Capecitabine—prostate cancer	3.45e-05	0.000167	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—prostate cancer	3.44e-05	0.000167	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.42e-05	0.000166	CcSEcCtD
Zopiclone—Fatigue—Capecitabine—prostate cancer	3.42e-05	0.000166	CcSEcCtD
Zopiclone—Hyperhidrosis—Prednisone—prostate cancer	3.41e-05	0.000166	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—prostate cancer	3.4e-05	0.000165	CcSEcCtD
Zopiclone—Pain—Capecitabine—prostate cancer	3.39e-05	0.000165	CcSEcCtD
Zopiclone—Constipation—Capecitabine—prostate cancer	3.39e-05	0.000165	CcSEcCtD
Zopiclone—Feeling abnormal—Docetaxel—prostate cancer	3.38e-05	0.000164	CcSEcCtD
Zopiclone—Diarrhoea—Etoposide—prostate cancer	3.37e-05	0.000164	CcSEcCtD
Zopiclone—Anorexia—Prednisone—prostate cancer	3.37e-05	0.000163	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—prostate cancer	3.35e-05	0.000163	CcSEcCtD
Zopiclone—Gastrointestinal pain—Docetaxel—prostate cancer	3.35e-05	0.000163	CcSEcCtD
Zopiclone—Tension—Epirubicin—prostate cancer	3.32e-05	0.000161	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—prostate cancer	3.31e-05	0.000161	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—prostate cancer	3.29e-05	0.00016	CcSEcCtD
Zopiclone—Back pain—Epirubicin—prostate cancer	3.27e-05	0.000159	CcSEcCtD
Zopiclone—Feeling abnormal—Capecitabine—prostate cancer	3.27e-05	0.000159	CcSEcCtD
Zopiclone—Dizziness—Etoposide—prostate cancer	3.26e-05	0.000158	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—prostate cancer	3.25e-05	0.000158	CcSEcCtD
Zopiclone—Gastrointestinal pain—Capecitabine—prostate cancer	3.24e-05	0.000157	CcSEcCtD
Zopiclone—Body temperature increased—Docetaxel—prostate cancer	3.24e-05	0.000157	CcSEcCtD
Zopiclone—Abdominal pain—Docetaxel—prostate cancer	3.24e-05	0.000157	CcSEcCtD
Zopiclone—Chills—Doxorubicin—prostate cancer	3.23e-05	0.000157	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.22e-05	0.000156	CcSEcCtD
Zopiclone—Insomnia—Prednisone—prostate cancer	3.19e-05	0.000155	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—prostate cancer	3.19e-05	0.000155	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—prostate cancer	3.18e-05	0.000154	CcSEcCtD
Zopiclone—Paraesthesia—Prednisone—prostate cancer	3.17e-05	0.000154	CcSEcCtD
Zopiclone—Urticaria—Capecitabine—prostate cancer	3.15e-05	0.000153	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—prostate cancer	3.14e-05	0.000152	CcSEcCtD
Zopiclone—Abdominal pain—Capecitabine—prostate cancer	3.13e-05	0.000152	CcSEcCtD
Zopiclone—Body temperature increased—Capecitabine—prostate cancer	3.13e-05	0.000152	CcSEcCtD
Zopiclone—Vomiting—Etoposide—prostate cancer	3.13e-05	0.000152	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—prostate cancer	3.13e-05	0.000152	CcSEcCtD
Zopiclone—Agitation—Epirubicin—prostate cancer	3.11e-05	0.000151	CcSEcCtD
Zopiclone—Dyspepsia—Prednisone—prostate cancer	3.11e-05	0.000151	CcSEcCtD
Zopiclone—Rash—Etoposide—prostate cancer	3.11e-05	0.000151	CcSEcCtD
Zopiclone—Dermatitis—Etoposide—prostate cancer	3.1e-05	0.000151	CcSEcCtD
Zopiclone—Headache—Etoposide—prostate cancer	3.09e-05	0.00015	CcSEcCtD
Zopiclone—Tension—Doxorubicin—prostate cancer	3.07e-05	0.000149	CcSEcCtD
Zopiclone—Decreased appetite—Prednisone—prostate cancer	3.07e-05	0.000149	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—prostate cancer	3.07e-05	0.000149	CcSEcCtD
Zopiclone—Malaise—Epirubicin—prostate cancer	3.05e-05	0.000148	CcSEcCtD
Zopiclone—Fatigue—Prednisone—prostate cancer	3.05e-05	0.000148	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—prostate cancer	3.04e-05	0.000148	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—prostate cancer	3.04e-05	0.000148	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—prostate cancer	3.03e-05	0.000147	CcSEcCtD
Zopiclone—Constipation—Prednisone—prostate cancer	3.02e-05	0.000147	CcSEcCtD
Zopiclone—Hypersensitivity—Docetaxel—prostate cancer	3.02e-05	0.000146	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—prostate cancer	3.01e-05	0.000146	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—prostate cancer	2.99e-05	0.000145	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—prostate cancer	2.95e-05	0.000143	CcSEcCtD
Zopiclone—Asthenia—Docetaxel—prostate cancer	2.94e-05	0.000143	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—prostate cancer	2.93e-05	0.000142	CcSEcCtD
Zopiclone—Nausea—Etoposide—prostate cancer	2.93e-05	0.000142	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—prostate cancer	2.92e-05	0.000142	CcSEcCtD
Zopiclone—Hypersensitivity—Capecitabine—prostate cancer	2.92e-05	0.000142	CcSEcCtD
Zopiclone—Feeling abnormal—Prednisone—prostate cancer	2.91e-05	0.000141	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—prostate cancer	2.91e-05	0.000141	CcSEcCtD
Zopiclone—Pruritus—Docetaxel—prostate cancer	2.9e-05	0.000141	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—prostate cancer	2.89e-05	0.000141	CcSEcCtD
Zopiclone—Gastrointestinal pain—Prednisone—prostate cancer	2.89e-05	0.00014	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—prostate cancer	2.88e-05	0.00014	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—prostate cancer	2.88e-05	0.00014	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—prostate cancer	2.88e-05	0.00014	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—prostate cancer	2.87e-05	0.000139	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—prostate cancer	2.85e-05	0.000138	CcSEcCtD
Zopiclone—Asthenia—Capecitabine—prostate cancer	2.85e-05	0.000138	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—prostate cancer	2.82e-05	0.000137	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—prostate cancer	2.82e-05	0.000137	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—prostate cancer	2.81e-05	0.000137	CcSEcCtD
Zopiclone—Urticaria—Prednisone—prostate cancer	2.81e-05	0.000136	CcSEcCtD
Zopiclone—Pruritus—Capecitabine—prostate cancer	2.81e-05	0.000136	CcSEcCtD
Zopiclone—Diarrhoea—Docetaxel—prostate cancer	2.8e-05	0.000136	CcSEcCtD
Zopiclone—Body temperature increased—Prednisone—prostate cancer	2.79e-05	0.000136	CcSEcCtD
Zopiclone—Abdominal pain—Prednisone—prostate cancer	2.79e-05	0.000136	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—prostate cancer	2.79e-05	0.000135	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—prostate cancer	2.77e-05	0.000134	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—prostate cancer	2.76e-05	0.000134	CcSEcCtD
Zopiclone—Infection—Epirubicin—prostate cancer	2.74e-05	0.000133	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—prostate cancer	2.71e-05	0.000132	CcSEcCtD
Zopiclone—Diarrhoea—Capecitabine—prostate cancer	2.71e-05	0.000132	CcSEcCtD
Zopiclone—Dizziness—Docetaxel—prostate cancer	2.71e-05	0.000131	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—prostate cancer	2.7e-05	0.000131	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—prostate cancer	2.7e-05	0.000131	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—prostate cancer	2.67e-05	0.00013	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—prostate cancer	2.67e-05	0.000129	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—prostate cancer	2.67e-05	0.000129	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—prostate cancer	2.66e-05	0.000129	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—prostate cancer	2.63e-05	0.000128	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—prostate cancer	2.63e-05	0.000128	CcSEcCtD
Zopiclone—Dizziness—Capecitabine—prostate cancer	2.62e-05	0.000127	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—prostate cancer	2.61e-05	0.000127	CcSEcCtD
Zopiclone—Vomiting—Docetaxel—prostate cancer	2.6e-05	0.000126	CcSEcCtD
Zopiclone—Hypersensitivity—Prednisone—prostate cancer	2.6e-05	0.000126	CcSEcCtD
Zopiclone—Rash—Docetaxel—prostate cancer	2.58e-05	0.000125	CcSEcCtD
Zopiclone—Dermatitis—Docetaxel—prostate cancer	2.58e-05	0.000125	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—prostate cancer	2.58e-05	0.000125	CcSEcCtD
Zopiclone—Headache—Docetaxel—prostate cancer	2.57e-05	0.000125	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—prostate cancer	2.56e-05	0.000124	CcSEcCtD
Zopiclone—Infection—Doxorubicin—prostate cancer	2.54e-05	0.000123	CcSEcCtD
Zopiclone—Asthenia—Prednisone—prostate cancer	2.53e-05	0.000123	CcSEcCtD
Zopiclone—Vomiting—Capecitabine—prostate cancer	2.52e-05	0.000122	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.52e-05	0.000122	CcSEcCtD
Zopiclone—Rash—Capecitabine—prostate cancer	2.5e-05	0.000121	CcSEcCtD
Zopiclone—Pruritus—Prednisone—prostate cancer	2.5e-05	0.000121	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—prostate cancer	2.5e-05	0.000121	CcSEcCtD
Zopiclone—Dermatitis—Capecitabine—prostate cancer	2.5e-05	0.000121	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—prostate cancer	2.49e-05	0.000121	CcSEcCtD
Zopiclone—Headache—Capecitabine—prostate cancer	2.48e-05	0.000121	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—prostate cancer	2.48e-05	0.00012	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—prostate cancer	2.47e-05	0.00012	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—prostate cancer	2.46e-05	0.00012	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—prostate cancer	2.46e-05	0.000119	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—prostate cancer	2.44e-05	0.000118	CcSEcCtD
Zopiclone—Nausea—Docetaxel—prostate cancer	2.43e-05	0.000118	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—prostate cancer	2.43e-05	0.000118	CcSEcCtD
Zopiclone—Diarrhoea—Prednisone—prostate cancer	2.42e-05	0.000117	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—prostate cancer	2.4e-05	0.000117	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.38e-05	0.000116	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—prostate cancer	2.38e-05	0.000116	CcSEcCtD
Zopiclone—Pain—Epirubicin—prostate cancer	2.36e-05	0.000115	CcSEcCtD
Zopiclone—Constipation—Epirubicin—prostate cancer	2.36e-05	0.000115	CcSEcCtD
Zopiclone—Nausea—Capecitabine—prostate cancer	2.36e-05	0.000114	CcSEcCtD
Zopiclone—Dizziness—Prednisone—prostate cancer	2.34e-05	0.000113	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.33e-05	0.000113	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—prostate cancer	2.31e-05	0.000112	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—prostate cancer	2.3e-05	0.000111	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—prostate cancer	2.28e-05	0.000111	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—prostate cancer	2.28e-05	0.00011	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—prostate cancer	2.27e-05	0.00011	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—prostate cancer	2.26e-05	0.00011	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—prostate cancer	2.25e-05	0.000109	CcSEcCtD
Zopiclone—Vomiting—Prednisone—prostate cancer	2.25e-05	0.000109	CcSEcCtD
Zopiclone—Rash—Prednisone—prostate cancer	2.23e-05	0.000108	CcSEcCtD
Zopiclone—Dermatitis—Prednisone—prostate cancer	2.22e-05	0.000108	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—prostate cancer	2.22e-05	0.000108	CcSEcCtD
Zopiclone—Headache—Prednisone—prostate cancer	2.21e-05	0.000107	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.21e-05	0.000107	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—prostate cancer	2.2e-05	0.000107	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—prostate cancer	2.19e-05	0.000107	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—prostate cancer	2.19e-05	0.000106	CcSEcCtD
Zopiclone—Pain—Doxorubicin—prostate cancer	2.19e-05	0.000106	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—prostate cancer	2.18e-05	0.000106	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—prostate cancer	2.18e-05	0.000106	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—prostate cancer	2.11e-05	0.000102	CcSEcCtD
Zopiclone—Nausea—Prednisone—prostate cancer	2.1e-05	0.000102	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—prostate cancer	2.09e-05	0.000101	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—prostate cancer	2.04e-05	9.88e-05	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—prostate cancer	2.03e-05	9.86e-05	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—prostate cancer	2.02e-05	9.81e-05	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—prostate cancer	2.02e-05	9.81e-05	CcSEcCtD
Zopiclone—Asthenia—Epirubicin—prostate cancer	1.98e-05	9.62e-05	CcSEcCtD
Zopiclone—Pruritus—Epirubicin—prostate cancer	1.95e-05	9.49e-05	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—prostate cancer	1.89e-05	9.17e-05	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—prostate cancer	1.88e-05	9.14e-05	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—prostate cancer	1.83e-05	8.9e-05	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—prostate cancer	1.83e-05	8.87e-05	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—prostate cancer	1.81e-05	8.78e-05	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—prostate cancer	1.76e-05	8.53e-05	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—prostate cancer	1.75e-05	8.49e-05	CcSEcCtD
Zopiclone—Rash—Epirubicin—prostate cancer	1.74e-05	8.45e-05	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—prostate cancer	1.74e-05	8.45e-05	CcSEcCtD
Zopiclone—Headache—Epirubicin—prostate cancer	1.73e-05	8.4e-05	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—prostate cancer	1.69e-05	8.2e-05	CcSEcCtD
Zopiclone—Nausea—Epirubicin—prostate cancer	1.64e-05	7.96e-05	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—prostate cancer	1.63e-05	7.89e-05	CcSEcCtD
Zopiclone—Rash—Doxorubicin—prostate cancer	1.61e-05	7.82e-05	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—prostate cancer	1.61e-05	7.82e-05	CcSEcCtD
Zopiclone—Headache—Doxorubicin—prostate cancer	1.6e-05	7.77e-05	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—prostate cancer	1.52e-05	7.37e-05	CcSEcCtD
Zopiclone—CYP2C9—Metabolism—ABCG5—prostate cancer	5.49e-06	5.96e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SULT1A1—prostate cancer	5.49e-06	5.96e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NCOA3—prostate cancer	5.46e-06	5.93e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—COMT—prostate cancer	5.45e-06	5.92e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.43e-06	5.89e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HPGD—prostate cancer	5.43e-06	5.89e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—prostate cancer	5.42e-06	5.89e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.36e-06	5.83e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTA1—prostate cancer	5.36e-06	5.82e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ITPR1—prostate cancer	5.33e-06	5.79e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTO1—prostate cancer	5.3e-06	5.76e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NAT2—prostate cancer	5.3e-06	5.76e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HSD3B2—prostate cancer	5.3e-06	5.76e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NCOA2—prostate cancer	5.27e-06	5.73e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.24e-06	5.7e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HPGDS—prostate cancer	5.21e-06	5.66e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2C19—prostate cancer	5.17e-06	5.62e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.1e-06	5.54e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.1e-06	5.54e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—LRP2—prostate cancer	5.08e-06	5.52e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PLCB2—prostate cancer	5.08e-06	5.52e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2C18—prostate cancer	5.08e-06	5.52e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ACHE—prostate cancer	5.05e-06	5.49e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTT1—prostate cancer	5.05e-06	5.49e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TYMS—prostate cancer	5.04e-06	5.47e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC5A5—prostate cancer	5.03e-06	5.46e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2A6—prostate cancer	4.99e-06	5.42e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—P4HB—prostate cancer	4.98e-06	5.41e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTM1—prostate cancer	4.98e-06	5.41e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.97e-06	5.4e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MTAP—prostate cancer	4.96e-06	5.39e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.96e-06	5.39e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—LPL—prostate cancer	4.89e-06	5.31e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—AKR1C3—prostate cancer	4.86e-06	5.28e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NQO1—prostate cancer	4.86e-06	5.28e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC22A1—prostate cancer	4.85e-06	5.27e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.84e-06	5.25e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.84e-06	5.25e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PRKACB—prostate cancer	4.83e-06	5.25e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.79e-06	5.21e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TH—prostate cancer	4.79e-06	5.2e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP17A1—prostate cancer	4.78e-06	5.19e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP3A4—prostate cancer	4.74e-06	5.14e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SULT2A1—prostate cancer	4.73e-06	5.13e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1A1—prostate cancer	4.72e-06	5.13e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.72e-06	5.12e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ERCC2—prostate cancer	4.68e-06	5.09e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1B1—prostate cancer	4.66e-06	5.06e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MED12—prostate cancer	4.65e-06	5.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ACSL4—prostate cancer	4.61e-06	5.01e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.61e-06	5.01e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GNG5—prostate cancer	4.61e-06	5.01e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NCOA2—prostate cancer	4.56e-06	4.95e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GGT1—prostate cancer	4.51e-06	4.9e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NCOA3—prostate cancer	4.44e-06	4.83e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NCOA1—prostate cancer	4.44e-06	4.83e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—UMPS—prostate cancer	4.42e-06	4.81e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PHGDH—prostate cancer	4.42e-06	4.81e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ARG2—prostate cancer	4.42e-06	4.81e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—MTHFR—prostate cancer	4.4e-06	4.78e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP19A1—prostate cancer	4.38e-06	4.76e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.37e-06	4.74e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC5A5—prostate cancer	4.35e-06	4.72e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—LDHB—prostate cancer	4.34e-06	4.71e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPARA—prostate cancer	4.32e-06	4.69e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.26e-06	4.63e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2E1—prostate cancer	4.24e-06	4.61e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HPGDS—prostate cancer	4.24e-06	4.6e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—RXRA—prostate cancer	4.22e-06	4.59e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2C19—prostate cancer	4.21e-06	4.58e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NQO1—prostate cancer	4.2e-06	4.56e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TH—prostate cancer	4.14e-06	4.49e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—UCP3—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TCN2—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA3—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PDHA1—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTT1—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ACHE—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.11e-06	4.47e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP3A4—prostate cancer	4.09e-06	4.45e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.07e-06	4.42e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—COMT—prostate cancer	4.07e-06	4.42e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.06e-06	4.41e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CAV1—prostate cancer	4.06e-06	4.41e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—prostate cancer	4.05e-06	4.4e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.05e-06	4.4e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1B1—prostate cancer	4.02e-06	4.37e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ITPR1—prostate cancer	3.99e-06	4.33e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.95e-06	4.29e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PRKACB—prostate cancer	3.93e-06	4.27e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.92e-06	4.26e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.92e-06	4.26e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GGT1—prostate cancer	3.9e-06	4.23e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.89e-06	4.23e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.88e-06	4.21e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NCOA1—prostate cancer	3.84e-06	4.17e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.84e-06	4.17e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.78e-06	4.11e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TYMS—prostate cancer	3.77e-06	4.09e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTM1—prostate cancer	3.72e-06	4.04e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NCOA2—prostate cancer	3.71e-06	4.03e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CG—prostate cancer	3.7e-06	4.02e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA2—prostate cancer	3.66e-06	3.98e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—LPL—prostate cancer	3.65e-06	3.97e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RXRA—prostate cancer	3.65e-06	3.97e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.62e-06	3.93e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ABCG5—prostate cancer	3.62e-06	3.93e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.55e-06	3.86e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.54e-06	3.84e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA1—prostate cancer	3.54e-06	3.84e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1A1—prostate cancer	3.53e-06	3.83e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—COMT—prostate cancer	3.52e-06	3.82e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—INS—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ERCC2—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NAT2—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTO1—prostate cancer	3.5e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.45e-06	3.75e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ITPR1—prostate cancer	3.44e-06	3.74e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CREBBP—prostate cancer	3.43e-06	3.73e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NQO1—prostate cancer	3.42e-06	3.71e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.39e-06	3.68e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TH—prostate cancer	3.37e-06	3.66e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PLCB2—prostate cancer	3.35e-06	3.64e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—LRP2—prostate cancer	3.35e-06	3.64e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.35e-06	3.64e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.35e-06	3.63e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.33e-06	3.62e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.31e-06	3.6e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—MTHFR—prostate cancer	3.29e-06	3.57e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—P4HB—prostate cancer	3.29e-06	3.57e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.28e-06	3.56e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TYMS—prostate cancer	3.25e-06	3.54e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CD—prostate cancer	3.25e-06	3.53e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPARA—prostate cancer	3.23e-06	3.51e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTM1—prostate cancer	3.22e-06	3.5e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.2e-06	3.47e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GGT1—prostate cancer	3.17e-06	3.45e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—LPL—prostate cancer	3.16e-06	3.43e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NCOA1—prostate cancer	3.12e-06	3.39e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.12e-06	3.39e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.08e-06	3.35e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NOS3—prostate cancer	3.07e-06	3.34e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MED12—prostate cancer	3.07e-06	3.33e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.05e-06	3.31e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GNG5—prostate cancer	3.04e-06	3.3e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CAV1—prostate cancer	3.03e-06	3.3e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ERCC2—prostate cancer	3.02e-06	3.29e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RXRA—prostate cancer	2.97e-06	3.23e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.93e-06	3.18e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.89e-06	3.14e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—COMT—prostate cancer	2.86e-06	3.11e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.85e-06	3.1e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.84e-06	3.09e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CB—prostate cancer	2.83e-06	3.08e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—prostate cancer	2.81e-06	3.05e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.8e-06	3.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.79e-06	3.04e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPARA—prostate cancer	2.79e-06	3.03e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.78e-06	3.02e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.76e-06	3e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.76e-06	2.99e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.71e-06	2.95e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ACHE—prostate cancer	2.71e-06	2.95e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.68e-06	2.91e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TYMS—prostate cancer	2.65e-06	2.88e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CAV1—prostate cancer	2.62e-06	2.85e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTM1—prostate cancer	2.62e-06	2.84e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—INS—prostate cancer	2.62e-06	2.84e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.61e-06	2.83e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.59e-06	2.82e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—LPL—prostate cancer	2.57e-06	2.79e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.57e-06	2.79e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CREBBP—prostate cancer	2.56e-06	2.78e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.51e-06	2.72e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.48e-06	2.7e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ERCC2—prostate cancer	2.46e-06	2.67e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTEN—prostate cancer	2.45e-06	2.66e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.45e-06	2.66e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.43e-06	2.64e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.39e-06	2.6e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—EP300—prostate cancer	2.34e-06	2.54e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.33e-06	2.53e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MTHFR—prostate cancer	2.31e-06	2.51e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NOS3—prostate cancer	2.29e-06	2.49e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.28e-06	2.48e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPARA—prostate cancer	2.27e-06	2.47e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—INS—prostate cancer	2.26e-06	2.46e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NQO1—prostate cancer	2.25e-06	2.45e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TH—prostate cancer	2.22e-06	2.41e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CREBBP—prostate cancer	2.21e-06	2.41e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.16e-06	2.35e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CAV1—prostate cancer	2.13e-06	2.32e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.12e-06	2.3e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.1e-06	2.28e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—prostate cancer	2.1e-06	2.28e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GGT1—prostate cancer	2.09e-06	2.27e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NCOA1—prostate cancer	2.06e-06	2.24e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.04e-06	2.22e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.03e-06	2.21e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NOS3—prostate cancer	1.98e-06	2.15e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RXRA—prostate cancer	1.96e-06	2.13e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.94e-06	2.11e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—COMT—prostate cancer	1.89e-06	2.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.88e-06	2.04e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.85e-06	2.01e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—INS—prostate cancer	1.84e-06	2e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.83e-06	1.99e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTEN—prostate cancer	1.83e-06	1.99e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.81e-06	1.97e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.8e-06	1.96e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TYMS—prostate cancer	1.75e-06	1.9e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—EP300—prostate cancer	1.75e-06	1.9e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CA—prostate cancer	1.73e-06	1.88e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.73e-06	1.88e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.71e-06	1.86e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—LPL—prostate cancer	1.69e-06	1.84e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.64e-06	1.78e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.62e-06	1.76e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NOS3—prostate cancer	1.61e-06	1.75e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTEN—prostate cancer	1.58e-06	1.72e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.53e-06	1.66e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—EP300—prostate cancer	1.51e-06	1.64e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPARA—prostate cancer	1.5e-06	1.63e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.49e-06	1.62e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.48e-06	1.6e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—AKT1—prostate cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CAV1—prostate cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTEN—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.28e-06	1.39e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—EP300—prostate cancer	1.23e-06	1.33e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—INS—prostate cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.13e-06	1.22e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NOS3—prostate cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—AKT1—prostate cancer	1.05e-06	1.15e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.82e-07	1.07e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—prostate cancer	9.73e-07	1.06e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—AKT1—prostate cancer	9.12e-07	9.9e-06	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.08e-07	9.87e-06	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTEN—prostate cancer	8.49e-07	9.22e-06	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—EP300—prostate cancer	8.1e-07	8.8e-06	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—AKT1—prostate cancer	7.42e-07	8.06e-06	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.99e-07	6.51e-06	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—AKT1—prostate cancer	4.89e-07	5.32e-06	CbGpPWpGaD
